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lithium perchlorate as a catalyst. The structures of the synthesized compounds were conﬁrmed by
IR and 1H NMR spectral data. Compounds (1–4) showed high antimicrobial activities against
Escherichia coli (NCIM2065), Serratia marcescens, Enterobacter cloacae, Shigella dysenteriae, Sal-
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Staphylococcus aureus (ATCC25292) as Gram-positive bacteria and Candida albicans as a fungus,
at low concentrations (2.5–10 mg/mL).
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Chitosan is typically obtained by deacetylation of chitin under
alkaline conditions, which is one of the most abundant organic
materials; chitosan is a linear polysaccharide, composed of
glucosamine and N-acetyl glucosamine units linked by (1–4)
glycosidic bonds (Alves and Manoa, 2008). Chitosan displays
interesting properties such as biocompatibility, biodegradabil-
ity (Kumar et al., 2004; Sanford et al., 1989) and its
degradation products are non-toxic, non-immunogenic and
non-carcinogenic (Muzzarelli, 1997; Bersch et al., 1995).Chitosan is also used as a ﬂocculant, clariﬁer, thickener, ﬁbre,
ﬁlm and afﬁnity chromatography column matrix gas-selective
membrane, plant disease resistance promoter, anti-cancer
agent, wound-healing promoting agent, and anti-microbial
agent (Wang et al., 2002; Hu et al., 2002; Shin et al., 2001). Re-
cently, there has been a growing interest in the chemical mod-
iﬁcation of chitosan in order to improve its solubility and
widen its applications. Derivatization by introducing small
functional groups to the chitosan structure, such as alkyl or
carboxymethyl groups (Jayakumar et al., 1015; Lu et al.,
2007) can drastically increase the solubility of chitosan at neu-
tral and alkaline pH values without affecting its cationic char-
acter. Chemical modiﬁcation of chitosan to generate new
bifunctional materials is of prime interest because the modiﬁ-
cation would not change the fundamental skeleton of chitosan,
would keep the original physicochemical and biochemical
properties and ﬁnally would bring new properties depending
on the nature of the group introduced. Recently, several meth-
ods have been reported to obtain phosphorylated derivatives
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chemical properties. They could exhibit bactericidal, biocom-
patible, bioabsorbable, osteoinductive and metal chelating
properties (Jayakumar et al., 2005, 2008; Amaral et al., 2005;
Wang et al., 2003; Fanny et al., 2005). Several techniques to
obtain phosphorylated derivatives of chitin have been pro-
posed. Phosphorylated chitin (Pchitin) and chitosan (P-chito-
san) were prepared by the reaction of chitin or chitosan with
orthophosphoric acid and urea in DMF (Hamodrakas et al.,
1982a,b), with phosphorous pentoxide in methane sulphonic
acid (Nishi et al., 1986), with phosphorous acid and formalde-
hyde (Ramos et al., 2003a,b), with diethyl chlorophosphate,
NaOH, n-hexane (Cardenas et al., 2006), and with H3PO4/
Et3PO4/P2O5/hexanol (Jayakumar and Tamura, 2006).
a-Aminophosphonates are among the most common orga-
nophosphorus derivatives and have been used as enzyme inhib-
itors, inhibitors of serine hydrolase, peptide mimics, antiviral,
antibacterial, antifungal, anticancer, anti-HIV, antibiotics,
herbicidal, and in other various applications (Li et al., 2007;
Prasad et al., 2007; Rao et al., 2008; Naydenova et al., 2008,
2010; Tusek-Bozic et al., 2008; Wang et al., 2008; Rezaei
et al., 2009; Onita et al., 2010; Zhang et al., 2010; Liu et al.,
2010). Various methods for the synthesis of a-aminophospho-
nates were reported. However, one pot Mannich-type (Wang
et al., 2001) process of carbonyl compounds, amines, and di-
phenyl phosphate in the presence of a Lewis acid catalyst re-
mains the most efﬁcient, simple, general, and high yielding
method (El Sayed et al., 2011; Caldes et al., 2011; Ning
et al., 2012; Reddy et al., 2012).
The present work was aimed to synthesize novel a-amino-
phosphonates containing chitosan moiety with the hope that
new antimicrobial agents could be developed. Speciﬁcally, we
grafted benzaldehyde, vanillin, p-chlorobenzaldehyde, cinna-
maldehyde and triphenylphosphite in the presence of lithium
perchlorate as a catalyst.
The biological activity of these modiﬁed chitosans was ex-
plored against Escherichia coli (NCIM2065), Serratia marces-
cens, Enterobacter cloacae, Shigella dysenteriae, Salmonella
enterica and Proteus vulgaris as Gram-negative bacteria, Bacil-
lus subtilis (PC1219) and Staphylococcus aureus (ATCC25292)
as Gram-positive bacteria and Candida albicans as a fungus, at
low concentrations (2.5–10 mg/mL).
To the best of our knowledge, no work on a-aminophosph-
onate conjugates with chitosan has been previously reported in
the literature.2. Experimental
2.1. Materials
Chitosan, benzaldehyde, p-chlorobenzaldehyde, cinnamalde-
hyde and vanillin were purchased from Aldrich.
2.2. Characterization techniques
IR spectra were recorded on a Perkin-Elmer 1430 Spectropho-
tometer using KBr disk technique. 1H NMR spectra were
recorded on a Bruker AC400 spectrometer operating at
400 MHz. The spectra were recorded in DMSO-d6. Chemical
shifts d are reported in parts per million (ppm) relative to
TMS. Assignments of signals are based on integration valuesand expected chemical shift values and have not been rigor-
ously conﬁrmed. Analytical thin layer chromatography
(TLC) was performed on EM silica gel F254 sheet (0.2 mm)
with chloroform/acetone (5:2 by volume) or petroleum ether
(40–60 C)/acetone (5:2 by volume) as developing eluents.
The spots were detected with UV Lamp Model UV GL-58.
Reagents and solvents were used from commercial sources
without puriﬁcation.
2.3. Synthesis of a-aminophosphonates containing chitosan
moiety (1–4)
Chitosan (4.0 mmol) was added to a stirred mixture of alde-
hydes (2.0 mmol) and a solution of LiClO4 in dichloromethane
(DCM) (3.0 mL, 15.0 mmol; 5 M). The mixture was stirred at
room temperature for 10 min before triphenylphosphite
(0.93 g, 3.0 mmol) was added. The mixture was stirred at room
temperature for 12–20 h before H2O (10 mL) and DCM
(10 mL) were added. The organic phase was separated and
the aqueous layer was extracted with (DCM) (2 · 10 mL).
The combined organics were dried over anhydrous Na2SO4
and the solvent was removed under reduced pressure to give
the crude product which was recrystallized from dimethyl
sulphoxide (DMSO) to give pure product.
2.3.1. Characterization of compound 1
IR (KBr): 3193, 1381, 900 cm1; 1H NMR (DMSO-d6): d 7.93
(br s, exch., 1H, NH), 7.51–6.79 (m, Ar-H), 5.55 (d, J = 15 Hz,
1H, CH), 4.71–1.23 (m, carbohydrate protons).
2.3.2. Characterization of compound 2
IR (KBr): 3404, 1382, 905 cm1; 1H NMR (DMSO-d6): d 9.25
(br s, exch., 1H, NH), 7.40–6.73 (m, Ar-H), 3.84 (s, 3H,
OCH3), 9.77 (s, exch., 1H, OH), 5.55 (d, J = 14 Hz, 1H,
CH), 4.70–1.23 (m, carbohydrate protons).
2.3.3. Characterization of compound 3
IR (KBr): 3420, 1382, 900 cm1; 1H NMR (DMSO-d6): d 9.28
(br s, exch., 1H, NH), 7.95–6.73 (m, Ar-H), 5.62 (d, J = 15 Hz,
1H, CH), 4.85–1.23 (m, carbohydrate protons).
2.3.4. Characterization of compound 4
IR (KBr): 3445, 1383, 896 cm1; 1H NMR (DMSO-d6): d 9.29
(br s, exch., 1H, NH), d 8.13–6.72 (m, Ar-H), 5.60 (d,
J = 17 Hz, 1H, CH), 4.66–1.23 (m, carbohydrate protons).2.4. Antimicrobial activities
2.4.1. Test microorganisms
2.4.1.1. Gram-negative bacteria. After Gram-staining proce-
dure, Gram-negative cells appear pink. The Gram-negative
bacteria used in this study were E. coli (which is known as
the back bone example for Gram-negative bacteria and cause
urinary infection, wound infection and gastroenteritis), Se.
marcescens, En. cloacae, Sh. dysenteriae, Sa. enterica and P.
vulgaris.
2.4.1.2. Gram-positive bacteria. The thick cell wall of a Gram-
positive organism retains the crystal violet dye used in the
Gram-staining procedure, so the stained cells appear purple
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study were B. subtilis and St. aureus. B. subtilis is mostly
involved in Urinary infection, wound, ulceration and septice-
mia. S. aureus is the mile stone of Gram-positive bacteria and
it is a causative agent of pneumonia, meningitis and food
poisoning.
The tested bacteria were obtained from the culture collec-
tion of Bacteriology Unit, Department of Botany, Faculty of
Science, Tanta University, Egypt.2.4.1.3. Fungi. Pathogenic fungi spatially yeasts are responsi-
ble for a number of diseases in humans and animals. A
number of pathogenic strains of fungi are represented in
C. albicans.
The tested organisms were obtained from the culture
collection of Mycology Unit, Department of Botany, Faculty
of Science, Tanta University, Egypt.
2.4.2. Evaluation of antimicrobial activity
The antimicrobial spectrum of the prepared polymers was
determined against the test bacteria on powdery samples by
the cut plug method (Pridham et al., 1956) on nutrient agar
which contained per litre: 10 g peptone, 5 g NaCl; 5 g beef
extract and 20 g agar (pH 7). The assay plates were seeded with
the test bacteria and fungi, after solidiﬁcation the wells were
made and ﬁlled with 20 mg powdery polymer. The plates were
incubated at 30 C for 24 h, after which the diameters of
inhibition zones were measured and the compounds which
produced inhibition zones were further assayed at different
concentrations in aqueous suspension in order to quantify
their inhibitory effects.
A loop full of each culture was placed in 10 ml of tenfold
diluted broth, which was then incubated overnight at 30 C.
At this stage, the cultures of the test bacteria containing
6 · 104 cells/ml and the test fungus containing 8 · 102 spores/
ml were used for the antimicrobial test. Since the polymers
were not completely soluble either in water or in different
solvents, they were suspended in a sterile ten times dilution
of the above nutrient broth medium to make a 0.05 g/ml
concentration and 0.5 ml was transferred to ﬂasks containing
sterile ten times diluted nutrient broth to give the ﬁnal concen-
trations of 0.0, 2.5, 5.0 and 10.0 mg/ml. Exposure of bacterial
cells to biocides was started when 0.2 ml of the culture contain-
ing 6 · 104 bacterial cells/ml or 8 · 102 fungal spores/ml was
added to 10 ml of the above biocide suspension which was
pre-equilibrated and shaken at 30 C as recommended by
Nakashima et al. (1987). At the same time, 0.2 ml of the same
culture was added to 10 ml of tenfold diluted nutrient broth,
decimal dilutions were prepared, and the starting number of
cells was counted by spread plate method. After 24 h contact,
1.0 ml aliquots were removed and mixed with 9.0 ml of tenfold
diluted nutrient broth and then decimal serial dilutions were
prepared from these dilutions and the surviving bacteria or
fungi were counted by the spread plate method. After inocula-
tion, the plates were inoculated at 30 C and the number of
colonies was counted after 24 h for bacteria and 48 h for fungi.
The ratio was carried out in triplicate every time. The ratio of
the colony numbers for the media containing the polymers (M)
and those without these compounds (C) was taken as surviving
cell number and by this value the antimicrobial activity was
evaluated.2.4.3. Minimal inhibitory concentrations (MICs)
The minimum inhibitory concentrations (MICs) of the synthe-
sized chitosan conjugate a-aminophosphonates (1–4) were
determined for each antimicrobial activity against selected
microorganisms by using agar diffusion method. The inhibi-
tion zone was measured in triplicates in four different concen-
trations (0.0, 2.5, 5.0 and 10.0 mg/mL) and the mean
value ± standard deviation (SD) is recorded in Table 3 and
Figs. 1–4.3. Results and discussion
3.1. Chemistry
As part of continuing work in the area of biologically
active compounds, we have recently reported the synthesis,
antimicrobial, and anticancer activities of a novel series of
a-aminophosphonates (Abdel-Megeed et al., 2012a,b,c,d,
2013).
Chitosan has an amino group at C-2 which is important
because amino groups are nucleophilic and readily react
with electrophilic reagents. In the present work, we exploited
this reactivity for grafting biologically active moieties into
the amino groups of chitosan to yield anti-microbial
chitosans.
As a test case, the reaction of chitosan with benzaldehyde
and triphenylphosphite in the presence of lithium perchlorate
as a catalyst in dichloromethane (DCM) at room temperature
was investigated. When chitosan (4 M equiv) was added a mix-
ture of benzaldehyde (2 M equiv) and lithium perchlorate
(15 M equiv) followed by the addition of triphenylphosphite
(3 M equiv) in DCM at room temperature for 12 h, the yield
of 1 was 85% (Table 1) after crystallization from dimethyl
sulphoxide (DMSO). Consequently, the reactions of chitosan
with various aldehydes (vanillin, p-chlorobenzaldehyde, cinna-
maldehyde) and triphenylphosphite in the presence of lithium
perchlorate as a catalyst were carried out in a similar
condition.
The crude products were puriﬁed by crystallization from di-
methyl sulphoxide (DMSO) to give a-aminophosphonates (1–
4) Scheme 1 in high yields Table 1.
Table 1 indicates that the reaction represented in Scheme 1
is general, simple, high yielding, involves easy work-up and
accommodates various substituents to produce various chito-
san conjugate a-aminophosphonates. The structures of (1–4)
were conﬁrmed by IR and 1H NMR spectroscopy.
The IR spectra of chitosan conjugate a-aminophospho-
nates (1–4) are characterized by the presence of absorption
bands within the 3193–3445 cm1 region corresponding to
the stretching vibrations of the NH groups. While the absorp-
tion bands at the 1381–1383 cm1 region are due to the sym-
metric stretching vibrations of the P‚O groups and
absorption bands within the 896–905 cm1 region are attrib-
uted to the P–O–C groups.
The 1H NMR spectra of chitosan conjugate a-aminophos-
phonates (1–4) showed a characteristic exchangeable singlet
within the 9.29–7.93 ppm region due to NH proton. The CH
protons resonated as doublet within the 5.62–5.55 (J= 14–
17) ppm region and the protons of the carbohydrate moiety
resonated at 4.85–1.23 ppm region.
Table 1 Synthesis of a-aminophosphonates containing chitosan moiety (1–4).
Yield (%)b Aldehyde Reaction time (h)a Product
85 Benzaldehyde 12 1
81 Vanillin 15 2
75 p-Chlorobenzaldehyde 16 3
88 Cinnamaldehyde 13 4
a Completion of the reaction was tested by the use of TLC.
b Yield of pure products as colourless crystals after crystallization from ethanol.
Table 2 Antimicrobial activity (inhibition zones mm) of
compounds (1–4).
Inhibition zone diameter a (mm) Microorganisms
Compounds
4 3 2 1
26 ± 1.2 24 ± 1.2 28 ± 0.6 25 ± 0.0 E. coli
24 ± 1.2 20 ± 1.2 23 ± 1.0 23 ± 2.1 S. marcescens
24 ± 1.0 29 ± 1.7 26 ± 1.7 28 ± 2.1 En. cloacae
40 ± 0.6 26 ± 3.2 36 ± 1.2 35 ± 0.0 Sh. dysenteriae
32 ± 1.5 21 ± 1.0 30 ± 1.0 30 ± 0.0 Sa. enterica
27 ± 1.2 23 ± 0.6 26 ± 2.5 27 ± 2.4 P. vulgaris
27 ± 2.0 20 ± 0.0 27 ± 2.9 27 ± 2.2 B. subtilis
31 ± 1.0 21 ± 1.0 20 ± 1.0 14 ± 0.5 St. aureus
11 ± 0.0 12 ± 0.0 12 ± 0.6 13 ± 0.05 C. albicans
a DMSO was added to different organisms as control and showed
no inhibition zone.
Figure 1 (MIC) of compound 1.
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3.2.1. Antimicrobial activities
The antimicrobial agents available on the market have various
drawbacks such as toxicity, narrow spectrum of activity and
some also exhibit drug–drug interactions. In view of the high
incidence of infections in immune compromised patients,
demands for new antimicrobial agents with a broad spectrum
of activity and good pharmacokinetic properties have increased
(Azizi and Saidi, 2003).
The synthesized chitosan conjugate a-aminophosphonates
(1–4) were screened for their in vitro antibacterial andTable 3 Minimum inhibitory concentrations (MICs) for compound
Minimum inhibitory concentrationsa (MICs) (mg/mL)
Compounds
4 3 2
5.0 ± 0.1 5.0 ± 0.4 2.5 ± 0.4
10.0 ± 0.5 10.0 ± 0.4 5.0 ± 0.3
2.5 ± 0.4 2.5 ± 0.0 5.0 ± 0.7
5.0 ± 0.6 5.0 ± 0.3 2.5 ± 0.5
5.0 ± 0.2 5.0 ± 0.4 2.5 ± 0.2
2.5 ± 0.4 2.5 ± 0.2 5.0 ± 0.4
10.0 ± 0.3 10.0 ± 1.1 5.0 ± 0.6
5.0 ± 0.4 5.0 ± 0.4 10.0 ± 0.9
20.0 ± 0.7 20.0 ± 1.4 20.0 ± 0.7
7.2 ± 5.5 7.2 ± 5.5 6.4 ± 5.6
a The standard antibiotic was Ampicillin (MIC = 5 lg/mL) and the staantifungal activities against E. coli (NCIM2065), S. marcescens,
En. cloacae, Sh. dysenteriae, Sa. enterica and P. vulgaris as
Gram-negative bacteria, B. subtilis (PC1219) and S. aureus
(ATCC25292) as Gram-positive bacteria and C. albicans as a
fungus. The inhibition zones were measured in triplicates and
the results of antimicrobial testing are reported in Table 2.
The results recorded in Table 2 showed that all compounds
have high activities against bacteria and fungi. Compound 1
showed high inhibition zone against the Gram negative bacte-
rium (S. dysenteriae) (35 mm). However, it showed relatively
lower activities against the tested fungus (C. albicans)
(13 mm). Compound 2 showed a similar trend as in case of
compound 1 against the Gram negative bacterium (S. dysente-
riae) (36 mm) and the tested fungus (C. albicans) (12 mm).
Compound 4 showed high inhibition zone against the Grams (1–4).
Microorganisms
1
5.0 ± 0.2 E. coli
5.0 ± 0.3 S. marcescens
10.0 ± 0.7 En. cloacae
2.5 ± 0.2 Sh. dysenteriae
2.5 ± 0.1 Sa. enteric
5.0 ± 0.3 P. vulgaris
5.0 ± 0.2 B. subtilis
10.0 ± 0.4 St. aureus
20.0 ± 0.3 C. albicans
7.2 ± 5.5 Mean MICs (lg/mL)
ndard antifungal was Itraconazole (50 mg/mL).
Figure 4 (MIC) of compound 4.
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ties against the tested fungus (C. albicans) (11 mm).
3.2.2. Minimal inhibitory concentrations (MICs)
Table 3 revealed that all compounds showed high antimicro-
bial activities at low concentrations (2.5–10.0 mg/mL). Com-
pound 1 showed MIC against S. dysenteriae and S. enterica
lower than the tested microorganisms. The highest MIC was
recorded against C. albicans. The results reported here look
promising, since the activity against Gram negative bacteria
is high. As it is well known that the structure of the Gramnegative bacteria has extra cell wall layers which make extra-
defense.
Compounds 1 and 2 showed higher activity against
S. dysenteriae, they kill 80% and 90% respectively of the
microorganism in the contact time at 2.5 mg/ml. Increasing
the concentration from 2.5 to 10.0 mg/ml killed 100% of the
species.
Compound 3 was more active against E. cloacae compared
to the other tested microorganisms; it killed 95% at concentra-
tion 10 mg/ml.
Compound 4 was inhibitory to S. dysenteriae than the
other test microorganisms. It killed 100% at concentration
10 mg/ml.
Generally, increasing the concentration from 2.5 to 10 mg/
ml increased the activity against all tested microorganisms and
the tested fungus was more resistant to the synthesized
compounds than all bacterial strains.
4. Conclusion
A convenient method for the synthesis of modiﬁed chitosan
was developed. The newly synthesized compounds exhibit
remarkable antimicrobial activities against Gram-positive,
Gram-negative bacteria and fungi at low concentrations.
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